Newsmeme!
Discover News you didn't know existed
Endocrine Gland
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
FDA Approves New Treatment for Type 2 Diabetes
Published February 6, 2010, 1:26 am, U. S. Food and Drug Administration
The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.
Oregon business wary of BPA ban in baby bottles, formula cans
Published February 4, 2010, 5:44 pm, The Oregonian
The federal government has "some concern" about the potential effects of the chemical on fetuses, infants and children. But Oregon business groups, including grocers and food processors, oppose a ban being considered by the Legislature.
BPA May Increase Kids’ Asthma Risk
Published February 4, 2010, 9:58 am, NewsInferno
The industrial, estrogenic chemical bisphenol A—BPA—has been in the news recently for its connection to a wide variety of adverse effects. An issue since BPA is in an enormous variety of consumer products, including products geared to infants and young children. Now, Science Daily reported that based on emerging studies out of the University of [...]
Bill would ban BPA in children's products
Published February 3, 2010, 7:25 am, The Capital
ANNAPOLIS - Child and family advocates, nurses, environmental organizations and business representatives Tuesday urged a Maryland House committee to support a bill banning a common chemical from infant and children's products.
Dr. Mercola: Mastering The Mystery Of Sleep
Published February 3, 2010, 6:40 am, The Huffington Post
Sleep is one of the great mysteries of life. Like gravity or the quantum field, sleep is so fundamental that scientists still don't know exactly what it is.
Repros Therapeutics receives FDA confirmation for initiating Androxal IND
Published February 2, 2010, 10:22 pm, News-Medical-Net
Repros Therapeutics Inc. today announced that the Company has received verbal confirmation from the Division of Metabolic and Endocrine Drug Products of the Food and Drug Agency that the Company may initiate its Investigational New Drug Application for the study of oral Androxal® in the treatment of hypogonadal men with Type II Diabetes (T2D) with a Phase IIa trial.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |